Roche Holding AG ROG, -0.27% said Friday that the Food and Drug Administration had approved Evrysdi, a treatment for spinal muscle atrophy in adults and most children. It is the second drug approved by the regulator to treat the rare disease. The therapy was developed by PTC Therapeutics Inc. PTCT, …
Read More »FDA approves Roche’s new spinal muscular atrophy fruit
